Classification of chronic kidney disease biomarkers to predict coronary artery calcium

Sterling McPherson1, Celestina Barbosa-Leiker, Robert Short

  • 1Washington State University, College of Nursing, Washington State University, Spokane, WA, USA. smcpherson05@wsu.edu

Insights

Higher serum phosphorus trajectories are linked to increased coronary artery calcification (CAC) even in healthy individuals. Understanding these phosphorus patterns may guide interventions for cardiovascular disease prevention.

Area of Science:

  • Nephrology
  • Cardiology
  • Biostatistics

Background:

  • The association between chronic kidney disease (CKD) and coronary artery calcification (CAC) is well-documented, primarily in patients with advanced CKD or ESRD and hyperphosphatemia.
  • Previous research often overlooks the role of serum phosphorus in individuals with normal kidney function.

Purpose of the Study:

  • To investigate distinct serum phosphorus trajectory classes, adjusted for estimated glomerular filtration rate (eGFR), and their association with CAC in a general community sample.
  • To determine if phosphorus levels, even within the typical range, predict CAC development and progression.

Main Methods:

  • Utilized growth mixture modeling to classify serum phosphorus and eGFR into four distinct trajectory classes.
  • Employed a two-part growth model to predict CAC as both a binary (onset) and continuous (accumulation) outcome based on these phosphorus trajectories.

Main Results:

  • Each incremental class increase in phosphorus trajectory was associated with a significant 97.9 Agatston unit increase in CAC.
  • This association is comparable in magnitude to established cardiovascular risk factors like age (55.3 AU increase) and inverse to female gender (-75.1 AU decrease).

Conclusions:

  • Serum phosphorus trajectories offer refined prediction of CAC, even within conventionally normal ranges.
  • Identifying specific phosphorus trajectory classes may establish clinically actionable thresholds for interventions targeting phosphorus reduction to mitigate cardiovascular risk.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...